Goldline Pharmaceutical Limited IPO
IPO Details
19.68
₹41.00 - 43.00
3,000
₹2,58,000
IPO
BSE
INE1CLW01015
25 (58.14)
IPO Timeline
Subscription Details
880.68x
1,662.35x
180.2x
569.72x
Goldline Pharmaceutical Limited Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 3000 | ₹2,58,000 |
| Retail (Max) | 2 | 6000 | ₹5,16,000 |
| HNI (Min) | 3 | 9000 | ₹7,74,000 |
FAQs on Goldline Pharmaceutical Limited IPO
What are allotment date for the Goldline Pharmaceutical Limited ?
Allotment: 15-05-2026
What are the open and close dates for the Goldline Pharmaceutical Limited IPO ?
Opens on 12-05-2026, closes on 14-05-2026.
Can NRIs apply for the Goldline Pharmaceutical Limited IPO through PL Capital?
Yes, NRIs can apply for the Goldline Pharmaceutical Limited IPO through PL Capital, subject to RBI and SEBI guidelines. Applications can be made via the NRE or NRO account route.
Where is the Goldline Pharmaceutical Limited IPO getting listed?
The Goldline Pharmaceutical Limited IPO will be listed on BSE. The exact listing date is 19-05-2026.
What is the minimum and maximum investment allowed in the Goldline Pharmaceutical Limited IPO?
The minimum investment for retail investors in the Goldline Pharmaceutical Limited IPO is ₹2,58,000. The maximum retail investment allowed is ₹5,16,000.
What is the GMP for this IPO?
Current GMP is 25 (58.14%)
